Board of directors

Position: Board member since 2014 and Chairman of the Board since 2020.

Education: Ph.D. in Genetics from Umeå University.

Board Committees: Member of the Remuneration Committee.

Experience: Former head of Life Science Investments at Industrifonden. He has more than 35 years’ experience from the pharma and biotech industry in executive positions at KabiGen, Symbicom AB, AstraZeneca AB, Karolinska Development AB and BioVitrum AB and as CEO for Arexis AB. Has held board positions in more than 25 Nordic biotech and Medtech companies.

Other current assignments: Chairman of the Board of Sixera Pharma AB, QureTech Bio AB, Omnio AB and Ignitus AB.

Independent/Dependent of the company/major owners: Independent in relation to the company and its management and in relation to major shareholders.

Holdings in Cinclus Pharma: Ordinary shares: 1,084,771 (via related parties).

Position: Board member since 2017.

Education: Master of Laws (LL.M.) from Uppsala University.

Board Committees: Chairman of the Remuneration Committee.

Experience: More than 20 years’ experience as a business lawyer, focusing entirely on advising clients within the life sciences industry on matters of commercial and corporate law. Previous work experience includes law firms Mannheimer Swartling, Lindahl and Bird & Bird. Since 2006 working for his own company IARU.

Other current assignments: Member of the Board in IARU Institutet för Affärsjuridisk Rådgivning i Uppsala AB. Chairman of the Board in Servacq AB.

Independent/Dependent of the company/major owners: Independent in relation to the company and its management and in relation to major shareholders.

Holdings in Cinclus Pharma: Ordinary shares: 94,435 (via related parties).

Position: Board member since 2021.

Education: Master in Finance and Business Administration from Stockholm School of Economics.

Board Committees: Chairman of the Audit Committee.

Experience: More than 20 years of experience within asset management and equity markets from SEB, Nordea, Odin Funds and Neonet Securities. Entrepreneurial experience from building and running Nordic Investor Services, an advisory consultant within global corporate governance, since 2002.

Other current assignments: Chairman of the Board in Factoringgruppen AB and member of the board in Stendörren Fastigheter AB (publ) and Occlutech AG.

Independent/Dependent of the company/major owners: Independent in relation to the company and its management and in relation to major shareholders.

Holdings in Cinclus Pharma: Ordinary shares: 50,270 (own and via related parties).

Position: Board member since 2016.

Education: Pharmacist, Ph.D of Pharmacy (pharma-cognosy), Adjunct Professor at Uppsala University.

Board Committees: Member of the Audit Committee.

Experience: Former Head of pharmacology at Pharmacia & Upjohn; VP clinical trials Quintiles Europe, CEO of Quintiles Scandinavia. Chairman of Aprea Therapeutics AB, Denator AB and Aprea Personal AB. Board member of Swedish Match AB, SOBI AB, Recipharm AB, Smartfish AB, Moberg Pharma AB, TFS Trial Form Support International AB, Apotek Produktion & Laboratorier AB and Industrifonden. Chairman of the Board of Bionor Pharma AS, BioArctic AB and Index Pharmaceutical Holding AB.

Other current assignments: CEO and Member of the Board of Rolfsen Consulting AB. Partner in Serendipity Partners.

Independent/Dependent of the company/major owners: Independent in relation to the company and its management and in relation to major shareholders.

Holdings in Cinclus Pharma: Ordinary Shares: 23,290 (own).

Position: Board member since 2026.

Education: M.B., B.Chir. from King’s College Hospital Medical School, London, and Professor of Medicine at McMaster University, Hamilton, Ontario.

Board Committees: -

Experience: Conducted extensive research into gastrointestinal diseases, published a large number of original articles and comprehensive summaries of research material, whilst simultaneously developing endoscopic quality improvements.

Other current assignments: Member of the Cinclus International Advisory Board, as well as Chief Innovation Officer and co-founder of A.I. VALI Inc.

Independent/Dependent of the company/major owners: Independent in relation to the company and its management and in relation to major shareholders.

Holdings in Cinclus Pharma: -

Position: Board member since 2026.

Education: Studied business law at Jönköping International Business School and business law, economics and finance at Georgia State University, the University of South Carolina and Lund University.

Board Committees: Member of the Audit Committee.

Experience: CFO and COO at Birdstep Technology ASA and CFO at Teligent Telecom.

Other current assignments: CFO and Managing Director for Europe at Veloxis/Calliditas Therapeutics.

Independent/Dependent of the company/major owners: Independent in relation to the company and its management and in relation to major shareholders.

Holdings in Cinclus Pharma: -

Position: Board member since 2026.

Education: Master’s degree from the Pharmacy Programme at Uppsala University.

Board Committees: -

Experience: CEO of Orexo AB, CCO of Banner Life Sciences and Senior Vice President of Santhera Pharmaceuticals Biogen; Global Commercial Strategy, International Commercial Operations and Hemophilia R&D.

Other current assignments: Board member and CEO of Shield Therapeutics and board member of Ardanza Biopharma.

Independent/Dependent of the company/major owners: Independent in relation to the company and its management and in relation to major shareholders.

Holdings in Cinclus Pharma: -